Plain-English translation of NCT05581121 on ClinicalTrials.gov ↗ ·
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial compares two treatment approaches for advanced cervical cancer. One group receives standard chemotherapy and radiation therapy. The other group first has surgery to remove lymph nodes near the aorta, then receives chemotherapy and radiation therapy tailored to their results. The study follows 510 patients for 5 years to see which approach helps people live longer without their cancer returning.
Doctors want to know if removing certain lymph nodes before standard treatment can help prevent cancer from spreading and improve survival. This treatment may help catch cancer in lymph nodes earlier and guide better chemotherapy and radiation planning.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of two groups. One group goes directly to chemotherapy and radiation therapy. The other group first undergoes surgery to remove lymph nodes near the aorta, then receives chemotherapy and radiation tailored to the surgical findings. You will have regular follow-up visits with your medical team for 5 years to monitor your health, check for cancer recurrence, and complete imaging and blood tests as needed.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
Czechia
France